CLINICAL_TRIALS
ClinicalTrials.gov record update
Almonertinib With Concurrent Radiotherapy in The Treatment of Unresectable, Stage Ⅲ Non-small-cell Lung Cancer Harboring EGFR Mutations: A PhaseⅡCohort Study
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04636593
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:52.419067+00:00
- Published At
- 2021-01-12T00:00:00+00:00
- Record Updated At
- 2021-01-12
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Non Small Cell Lung Cancer", "Stage III NSCLC", "EGFR Activating Mutation"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-01-12"- protocolSection.identificationModule.nctId
"NCT04636593"- protocolSection.identificationModule.officialTitle
"Almonertinib With Concurrent Radiotherapy in The Treatment of Unresectable, Stage \u2162 Non-small-cell Lung Cancer Harboring EGFR Mutations: A Phase\u2161Cohort Study"- protocolSection.statusModule.overallStatus
"UNKNOWN"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.